ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients
/PRNewswire/ -- ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to maximize...
New Data Evaluating ImpediMed's SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022
/PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce that two abstracts evaluating use of ImpediMed's SOZO® Digital Health Platform in heart...